Diabetes Treatment Market

Diabetes Treatment Market by Products (Injectable Diabetes Drugs, Oral Drugs, Insulin Therapies, Insulin Pumps, Insulin Injection Devices, and Blood Glucose Monitoring Systems), Types (Insulin, Oral Hypoglycemic Drugs, Non-Insulin Injectable Drugs, and Others), End Users (Hospital, Personal Use, and Clinic), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028

  • Report ID: HC-652
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 148
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global diabetes treatment market size is anticipated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the introduction of new analytical technologies and developments of diabetes treatment.

Diabetes is a health condition in which the body is unable to utilize the glucose produced in the body. Diabetes treatment is necessary to enhance the treatment procedure of blood glucose monitoring system. Additionally, diabetes treatment helps in enhancing the people’s living habits, as disease control effect is gaining significant traction in the recent time. Increasing obesity and standards of living, are also boosting the adoption of diabetes treatment. Additionally, the development of type one and type two diabetes treatments are projected to favor pharmaceutical companies in the long term. The diabetes treatment market has an enhanced research & development pipeline.

Diabetes drugs are the medicines used for the treatment of type one and type two by reducing the blood glucose level in the body. Blood glucose is managed by drugs such as januvia and byetta. There is a substantial improvement in the blood glucose monitoring systems, in order to manage the critical insulin therapy and make it less painful, accurate and easy to use. There are several types of drugs involved in the diabetes treatment which are consumed either by oral route or by intravenous or subcutaneous routes. The increasing level of sedentary lifestyles and obesity in global population has led to the rise in incidents of diabetes across the globe. Additionally, human insulin and analogues markets are projected to fuel the diabetes treatment market growth during the forecast period.

Global Diabetes Treatment Market Summary

Market Drivers, Restraints, Trends, and Opportunities

  • Large number of emerging diabetes drugs are under clinical observation by pharmaceutical companies, which is expected to enter the market during the forecast period.
  • Growing incidence of type one and type two diabetes is projected to spur the diabetes treatment market.
  • Stimulating innovations and price reductions are some of the key factors boosting the diabetes treatment market growth.
  • The diabetic treatment industry is encouraging the adoption of combinational drug treatments thus hindering the growth of monotherapy treatment during the forecast period.
  • Technological and commercial progress in the diabetes treatment market is projected to fuel the market growth during the forecast period.
  • Increasing demand for medication targeting long term weight reduction and other related conditions due to the prevalence of type two diabetes is projected to propel the market growth.

Scope of the Report

The report on the diabetes treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Diabetes Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Injectable Diabetes Drugs, Oral Drugs, Insulin Therapies, Insulin Pumps, Insulin Injection Devices, and Blood Glucose Monitoring Systems), Types (Insulin, Oral Hypoglycemic Drugs, Non-Insulin Injectable Drugs, and Others), End Users (Hospital, Personal Use, and Clinic)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Teva Pharmaceuticals Pvt Ltd., Novo Nordisk AS, Merck & Company Inc., Medtronic Inc., Johnson & Johnson, Home Diagnostics Inc., Bayer Healthcare AG, Amylin Pharmaceuticals Inc., and Abbott Laboratories

 

Global Diabetes Treatment Market Segment Insights

Oral drugs projected to represent a considerable market share
On the basis of products, the market is categorized into injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices, and blood glucose monitoring systems. The oral drug segment is projected to represent a considerable market share during the forecast period. the growing prevalence of type 1 and type 2 diabetes is driving the segment growth. Moreover, oral drugs consumption is preferred by most of the diabetic patients.

Global Diabetes Treatment Market By Product

Insulin segment is expected to constitute a significant market share
In terms of types, the market is bifurcated into insulin, oral hypoglycemic drugs, non-insulin injectable drugs, and others. The insulin segment is expected to constitute a significant market share during the forecast period. The growth of the segment is attributed to the increasing number of type 1 diabetes among the global population. However, some of the type 2 diabetes patients also rely on insulin. Around 10% of the total diabetes population is of type 1, the insulin intake is higher among this population. Growing awareness about the benefits of insulin for diabetes patients in emerging economies is driving the segment growth. Additionally, rapid development in insulin delivery systems, drug and analog development by key companies, and the growth in geriatric population, is projected to fuel the segment growth. For instance, in 2019, in the insulin segment, the basal insulin accounted for around 46% market share. The International Diabetes Federation states, diabetes patients spent 760 billion in 2019, and a large amount of it was spent by Type-1 diabetes patients on insulin drugs.

Hospital segment is expected to account for a large a market share
Based on end uses, the market is classified into hospital, personal use and clinic. The hospital segment is expected to account for a large market share during the forecast period. As a large number of patients prefer hospitals for initial diagnostic and treatment of diabetes, this segment is projected to acquire a significant market share.

Global Diabetes Treatment Market By End-users

North America is expected to represent a considerable market share
in terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is expected to represent a considerable market share during the forecast period. Growing investment of various government organizations in the research and development activities is projected to boost the regional growth of the market. Additionally, increasing prevalence of diabetes in this region is driving the regional growth. Growing awareness of consumers regarding the novel anti-diabetic drugs, new launch of anti-diabetic drugs and favorable reimbursement policies are expected to boost the regional growth of the market.

Global Diabetes Treatment Market By Region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Diabetes Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Diabetes Treatment Market - Supply Chain
  4.5. Global Diabetes Treatment Market Forecast
     4.5.1. Diabetes Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Diabetes Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Diabetes Treatment Market Absolute $ Opportunity
5. Global Diabetes Treatment Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Diabetes Treatment Market Size and Volume Forecast by Types
     5.3.1. Insulin
     5.3.2. Oral Hypoglycemic Drugs
     5.3.3. Non-Insulin Injectable Drugs
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Diabetes Treatment Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Diabetes Treatment Market Size and Volume Forecast by End Users
     6.3.1. Hospital
     6.3.2. Personal Use
     6.3.3. Clinic
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Diabetes Treatment Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Diabetes Treatment Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Diabetes Treatment Demand Share Forecast, 2019-2026
8. North America Diabetes Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Diabetes Treatment Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Diabetes Treatment Market Size and Volume Forecast by Types
     8.4.1. Insulin
     8.4.2. Oral Hypoglycemic Drugs
     8.4.3. Non-Insulin Injectable Drugs
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Diabetes Treatment Market Size and Volume Forecast by End Users
     8.7.1. Hospital
     8.7.2. Personal Use
     8.7.3. Clinic
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Diabetes Treatment Demand Share Forecast, 2019-2026
9. Latin America Diabetes Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Diabetes Treatment Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Diabetes Treatment Market Size and Volume Forecast by Types
     9.4.1. Insulin
     9.4.2. Oral Hypoglycemic Drugs
     9.4.3. Non-Insulin Injectable Drugs
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Diabetes Treatment Market Size and Volume Forecast by End Users
     9.7.1. Hospital
     9.7.2. Personal Use
     9.7.3. Clinic
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Diabetes Treatment Demand Share Forecast, 2019-2026
10. Europe Diabetes Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Diabetes Treatment Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Diabetes Treatment Market Size and Volume Forecast by Types
     10.4.1. Insulin
     10.4.2. Oral Hypoglycemic Drugs
     10.4.3. Non-Insulin Injectable Drugs
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Diabetes Treatment Market Size and Volume Forecast by End Users
     10.7.1. Hospital
     10.7.2. Personal Use
     10.7.3. Clinic
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Diabetes Treatment Demand Share Forecast, 2019-2026
11. Asia Pacific Diabetes Treatment Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Diabetes Treatment Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Diabetes Treatment Market Size and Volume Forecast by Types
     11.4.1. Insulin
     11.4.2. Oral Hypoglycemic Drugs
     11.4.3. Non-Insulin Injectable Drugs
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Diabetes Treatment Market Size and Volume Forecast by End Users
     11.7.1. Hospital
     11.7.2. Personal Use
     11.7.3. Clinic
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Diabetes Treatment Demand Share Forecast, 2019-2026
12. Middle East & Africa Diabetes Treatment Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Diabetes Treatment Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Diabetes Treatment Market Size and Volume Forecast by Types
     12.4.1. Insulin
     12.4.2. Oral Hypoglycemic Drugs
     12.4.3. Non-Insulin Injectable Drugs
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Diabetes Treatment Market Size and Volume Forecast by End Users
     12.7.1. Hospital
     12.7.2. Personal Use
     12.7.3. Clinic
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Diabetes Treatment Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Diabetes Treatment Market: Market Share Analysis
  13.2. Diabetes Treatment Distributors and Customers
  13.3. Diabetes Treatment Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Teva Pharmaceuticals Pvt Ltd.
     13.4.2. Novo Nordisk AS
     13.4.3. Merck & Company Inc.
     13.4.4. Medtronic Inc.
     13.4.5. Johnson & Johnson
     13.4.6. Home Diagnostics Inc.
     13.4.7. Bayer Healthcare AG
     13.4.8. Amylin Pharmaceuticals Inc.
     13.4.9. Abbott Laboratories
Segments Covered in the report
The global diabetes treatment market has been segmented on the basis of

Products
  • Injectable Diabetes Drugs
  • Oral Drugs
  • Insulin Therapies
  • Insulin Pumps
  • Insulin Injection Devices
  • Blood Glucose Monitoring Systems
Types
  • Insulin
  • Oral Hypoglycemic Drugs
  • Non-Insulin Injectable Drugs
  • Others
End Users
  • Hospital
  • Personal Use
  • Clinic
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Teva Pharmaceuticals Pvt Ltd.
  • Novo Nordisk AS
  • Merck & Company Inc.
  • Medtronic Inc.
  • Johnson & Johnson
  • Home Diagnostics Inc.
  • Bayer Healthcare AG
  • Amylin Pharmaceuticals Inc.
  • Abbott Laboratories

Some of the key players in the global diabetes treatment market include Teva Pharmaceuticals Pvt Ltd., Novo Nordisk AS, Merck & Company Inc., Medtronic Inc., Johnson & Johnson, Home Diagnostics Inc., Bayer Healthcare AG, Amylin Pharmaceuticals Inc., and Abbott Laboratories.

Drug manufacturers are focusing on development of medication for related problems such as kidney disease, strokes, heart disease, and obesity, are evaluating medicines in clinical trials for treating diabetes.

Global Diabetes Treatment Market By Key Players

Buy Report